Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does METOPROLOL Cause Concomitant disease aggravated? 46 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 46 reports of Concomitant disease aggravated have been filed in association with METOPROLOL (metoprolol succinate). This represents 0.1% of all adverse event reports for METOPROLOL.

46
Reports of Concomitant disease aggravated with METOPROLOL
0.1%
of all METOPROLOL reports
4
Deaths
32
Hospitalizations

How Dangerous Is Concomitant disease aggravated From METOPROLOL?

Of the 46 reports, 4 (8.7%) resulted in death, 32 (69.6%) required hospitalization, and 1 (2.2%) were considered life-threatening.

Is Concomitant disease aggravated Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for METOPROLOL. However, 46 reports have been filed with the FAERS database.

What Other Side Effects Does METOPROLOL Cause?

Drug ineffective (3,434) Dyspnoea (3,428) Dizziness (3,275) Hypotension (3,213) Completed suicide (2,959) Fatigue (2,784) Off label use (2,580) Toxicity to various agents (2,404) Bradycardia (2,024) Nausea (1,894)

What Other Drugs Cause Concomitant disease aggravated?

SACUBITRIL\VALSARTAN (533) SECUKINUMAB (461) FINGOLIMOD (425) MACITENTAN (286) OMALIZUMAB (186) SELEXIPAG (166) METHOTREXATE (150) RUXOLITINIB (142) OCTREOTIDE (125) BOSENTAN (123)

Which METOPROLOL Alternatives Have Lower Concomitant disease aggravated Risk?

METOPROLOL vs METRELEPTIN METOPROLOL vs METRONIDAZOLE METOPROLOL vs METRONIDAZOLE\METRONIDAZOLE METOPROLOL vs METYRAPONE METOPROLOL vs MEXILETINE

Related Pages

METOPROLOL Full Profile All Concomitant disease aggravated Reports All Drugs Causing Concomitant disease aggravated METOPROLOL Demographics